galantamine has been researched along with quercetin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| French, CJ; Hillhouse, BJ; Hudson, JB; López, A; Ming, DS; Towers, GH | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Decker, M; Fleck, C; Heilmann, J; Kling, B; Kraus, B; Lupp, A; Zenger, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Basile, L; Gazioglu, I; Ginex, T; Guccione, S; Kucukislamoglu, M; Kurt, BZ; Sonmez, F | 1 |
| Al-Hamashi, AA; Alhadidi, Q; Handunnetti, SM; Perera, L; Samaradivakara, SP; Samarasekera, R; Shah, ZA; Slama, JT; Taylor, WR; Tillekeratne, LMV; Weerasena, OVDSJ | 1 |
| Altomare, CD; Carrieri, A; Catto, M; de Candia, M; De Palma, A; Ivanova, OA; Pisani, L; Purgatorio, R; Toma, M; Voskressensky, LG | 1 |
| Bian, ZY; Guo, C; Huang, LF; Liu, RC; Liu, RZ; Ren, B; Tang, JJ | 1 |
| Antunes, CM; Burke, AJ; Carreiro, EP; Costa, AR; Ernesto, S; Pinto, F; Rodrigues, B | 1 |
10 other study(ies) available for galantamine and quercetin
| Article | Year |
|---|---|
Bioactive constituents from Iryanthera megistophylla.
Topics: Biological Factors; Myristicaceae; Spectrum Analysis | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo.
Topics: Acetylcholinesterase; Allosteric Regulation; Animals; Butyrylcholinesterase; Cell Count; Cell Line; Cell Survival; Cholinesterase Inhibitors; Cognition; Eels; Female; Glutamic Acid; Hepatic Stellate Cells; Horses; Lipid Peroxidation; Liver; Maze Learning; Mice; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Silybin; Silymarin; Tacrine | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzofurans; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles; Torpedo; Urea | 2015 |
A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Dipterocarpaceae; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Molecular Structure; Neuroprotective Agents; PC12 Cells; Plant Bark; Rats; Resveratrol; Sri Lanka | 2018 |
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Topics: Amyloid beta-Peptides; Azepines; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Free Radical Scavengers; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Binding; Protein Multimerization; Structure-Activity Relationship | 2019 |
Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships.
Topics: Acetophenones; Acetylcholinesterase; Animals; Biphenyl Compounds; Cell Line; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Discovery; Electrophorus; Enzyme Inhibitors; Humans; Imidazoles; Lipopolysaccharides; Mice; Molecular Structure; Neuroprotective Agents; Nitric Oxide; Oximes; Picrates; Rats; Structure-Activity Relationship | 2022 |
Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer's Agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Drug Design; Galantamine; Humans; Hydrogen Peroxide; Neuroprotective Agents; Quercetin; Structure-Activity Relationship | 2023 |